Rapid Micro Biosystems (RPID) Free Cash Flow (2020 - 2026)

Rapid Micro Biosystems (RPID) has 7 years of Free Cash Flow data on file, last reported at -$15.1 million in Q1 2026.

• For the quarter ending Q1 2026, Free Cash Flow fell 60.6% year-over-year to -$15.1 million; the trailing twelve-month figure through Mar 2026 stood at -$36.8 million (up 5.24% YoY), and the FY2025 full-year result was -$31.1 million, up 31.73% from the prior year.
• Free Cash Flow declined to -$15.1 million in Q1 2026, from -$2.5 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of -$2.5 million in Q4 2025 to a low of -$20.7 million in Q3 2022.
• A 5-year average of -$11.5 million and a median of -$9.7 million in 2023 frame the typical range for Free Cash Flow.
• Across the five-year window, Free Cash Flow plunged 67.44% in 2023 and surged 77.77% in 2025, its largest moves.
• Tracing RPID's Free Cash Flow over 5 years: stood at -$5.5 million in 2022, then tumbled by 67.44% to -$9.3 million in 2023, then retreated by 21.08% to -$11.2 million in 2024, then surged by 77.77% to -$2.5 million in 2025, then tumbled by 502.84% to -$15.1 million in 2026.
• Business Quant data shows RPID's Free Cash Flow at -$15.1 million in Q1 2026, -$2.5 million in Q4 2025, and -$9.7 million in Q3 2025.